Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
Clinical trial NCT06429176 · RECRUITING
Trial details
- NCT number
- NCT06429176
- Sponsor
- SpliSense Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2027-10-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.